Fundamentals-based quality & risk · not a recommendation
Yatharth Hospital & Trauma Care Services Ltd scores 63/100 (Watch) on the Orion Score — moderate business quality (55), strong growth (91), strong balance-sheet safety (80) and rich valuation (30). A fundamentals-based quality & risk score, not a buy/sell recommendation.
Risk checks
Forensic accounting
Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check
Technical / Momentum
Price Trend
71/100
Technical momentum companion — separate from the fundamentals-based Orion Score.
Unlock with Pro
Upgrade →Q4 FY2026
Revenue & Profit in ₹ Crores
| Quarter | Revenue | Net Profit | OPM | EPS |
|---|---|---|---|---|
| Q4 2026 | ₹341.56 | ₹47.52 | 14.6% | ₹4.93 |
| Q3 2026 | ₹320.47 | ₹45.35 | 15.7% | ₹4.71 |
| Q2 2026 | ₹279.42 | ₹41.24 | 16.3% | ₹4.28 |
| Q1 2026 | ₹257.77 | ₹42.04 | 19.2% | ₹4.36 |
| Q4 2025 | ₹233.03 | ₹38.72 | 19.5% | ₹4.37 |
Revenue & Profit in ₹ Crores (Yearly)
| Year | Revenue | Net Profit | EBITDA | OPM |
|---|---|---|---|---|
| FY 2026 | ₹1,207.17 | ₹175.38 | ₹317.9 | 16.9% |
| FY 2025 | ₹885.62 | ₹130.54 | ₹236.42 | 19.0% |
| FY 2024 | ₹670.55 | ₹114.47 | ₹195.55 | 22.8% |
| FY 2023 | ₹520.29 | ₹65.77 | ₹136.57 | 20.7% |
Top companies in the same sector by market cap
| Company | Mkt Cap | P/E | ROCE | ROE | D/E | OPM |
|---|---|---|---|---|---|---|
| YATHARTH ★ | ₹7,794 Cr | 44.45 | 9.74% | 9.89% | 0.15x | 14.61% |
| SUNPHARMA | ₹4,27,609 Cr | 37.32 | 15.73% | 14.72% | 0.06x | 18.90% |
| MAXHEALTH | ₹95,110 Cr | 66.21 | 11.94% | 14.33% | 0.32x | 22.56% |
| AUROPHARMA | ₹88,228 Cr | 25.64 | 12.55% | 9.93% | 0.21x | 15.11% |
| ASTERDM | ₹71,372 Cr | 108.60 | 8.93% | 10.07% | 0.46x | 13.98% |
| ABBOTINDIA | ₹59,615 Cr | 38.42 | 36.14% | 34.46% | 0.04x | 27.01% |
All values in ₹ Crores
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total Assets | ₹1,731.18 | ₹1,019.33 | ₹485.97 | ₹426.02 |
| Equity | ₹1,605.46 | ₹874.32 | ₹182.96 | ₹116.89 |
| Total Debt | ₹11.59 | ₹84.65 | ₹267.41 | ₹263.77 |
| Cash | ₹204.96 | ₹81.4 | ₹37.23 | ₹11.66 |
| Net Debt | — | ₹1.66 | ₹226.55 | ₹246.53 |
| Working Capital | ₹771.15 | ₹443.03 | ₹76.75 | ₹12.29 |
Q1 FY2027
Quarter-over-Quarter Trend
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Q1 FY2027 | 56.94% ↑ | 6.62% ↑ | 5.41% ↓ | 31.03% ↑ |
| Q3 FY2026 | 55.8% ↓ | 6.18% ↓ | 11.02% ↑ | 27.01% ↑ |
| Q2 FY2026 | 61.64% | 6.51% ↑ | 8.71% ↓ | 23.16% ↑ |
| Q1 FY2026 | 61.64% | 4.34% ↓ | 13.52% ↓ | 20.5% ↑ |
| Q4 FY2025 | 61.64% ↑ | 4.45% ↓ | 13.56% ↑ | 20.35% ↑ |
| Q3 FY2025 | 61.44% ↓ | 9.78% ↑ | 11.5% ↑ | 17.27% ↓ |
| Q2 FY2025 | 66.54% | 6.28% ↑ | 6.97% ↓ | 20.2% ↑ |
| Q1 FY2025 | 66.54% | 4.9% | 9.4% | 19.16% |
No recent corporate actions
15 mutual fund schemes
Ask: "Is Yatharth Hospital & Trauma Care Services Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation
Analyse with OrionGet free stock analysis, market insights, and investment ideas delivered to your inbox.
No spam. Unsubscribe anytime.
Yatharth Hospital & Trauma Care Services Ltd is listed on the NSE under the Healthcare sector, Hospital industry. ISIN: INE0JO301016. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.